Shihong Shen

Prof. Dr. Shihong Shen

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2017 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
Shihong ShenShihong Shen
Shihong Shen
YWYoushen Wu
Youshen Wu
YLYongchun Liu
Yongchun Liu
DWDaocheng Wu
Daocheng Wu
Drug molecules transformed into nanoparticles or endowed with nanostructures with or without the aid of carrier materials are referred to as “nanomedicines” and can overcome some inherent drawbacks of free drugs, such as poor water solubility, high drug dosage, and short drug half-life in vivo. However, most of the existing nanomedicines possess the drawback of low drug-loading (generally less than 10%) associated with more carrier materials. For intravenous administration, the extensive use of carrier materials might cause systemic toxicity and impose an extra burden of degradation, metabolism, and excretion of the materials for patients. Therefore, on the premise of guaranteeing therapeutic effect and function, reducing or avoiding the use of carrier materials is a promising alternative approach to solve these problems. Recently, high drug-loading nanomedicines, which have a drug-loading content higher than 10%, are attracting increasing interest. According to the fabrication strategies of nanomedicines, high drug-loading nanomedicines are divided into four main classes: nanomedicines with inert porous material as carrier, nanomedicines with drug as part of carrier, carrier-free nanomedicines, and nanomedicines following niche and complex strategies. To date, most of the existing high drug-loading nanomedicines belong to the first class, and few research studies have focused on other classes. In this review, we investigate the research status of high drug-loading nanomedicines and discuss the features of their fabrication strategies and optimum proposal in detail. We also point out deficiencies and developing direction of high drug-loading nanomedicines. We envision that high drug-loading nanomedicines will occupy an important position in the field of drug-delivery systems, and hope that novel perspectives will be proposed for the development of high drug-loading nanomedicines.


8 December 2020 in ACS Nano
Verified
Journal Article
Closed access
YWYa Wang
Ya Wang
SLSiyuan Luo
Siyuan Luo
YWYoushen Wu
Youshen Wu
PTPeng Tang
Peng Tang
JLJiajun Liu
Jiajun Liu
DWDaocheng Wu
Daocheng Wu

1 April 2022 in Chemical Engineering Journal
Verified
Journal Article
Closed access
YYYang Yuan
Yang Yuan
DFDaidi Fan
Daidi Fan
Shihong ShenShihong Shen
Shihong Shen
XMXiaoxuan Ma
Xiaoxuan Ma

14 November 2018 in Advanced Functional Materials
Verified
Journal Article
Closed access
PDF file
YWYa Wang
Ya Wang
YWYoushen Wu
Youshen Wu
KLKe Li
Ke Li
Shihong ShenShihong Shen
Shihong Shen
ZLZeying Liu
Zeying Liu
DWDaocheng Wu
Daocheng Wu